LONDON: Britain hopes for millions of doses of the Pfizer/BioNTech COVID-19 vaccine by the end of the year but the final figure will depend on how quickly it can be …
PfizerBioNTech
-
-
By: Reuters | London | December 3, 2020 1:35:56 am Britain granted emergency use approval to the Pfizer-BioNTech vaccine in record time — just 23 days since Pfizer published the …
-
Pfizer and BioNTech say they’ve won permission Wednesday for emergency use of their Covid-19 vaccine in Britain, the world’s first coronavirus shot that’s backed by rigorous science — and a …
-
A general view of Pfizer Manufacturing Belgium in Puurs, Belgium. Pfizer and BioNTech say they’ve won permission Wednesday, Dec. 2, 2020, for emergency use of their COVID-19 vaccine in Britain, …
-
The Pfizer/BioNTech COVID-19 vaccine has been approved for use in the UK and will be made available from next week, U.K. Health Secretary Matt Hancock said. U.K. regulators are the …
- General
‘Historic’: UK Becomes First Nation to Approve Pfizer-BioNTech Vaccine for Use, Rollout Next Week
Britain on Wednesday became the first country in the world to approve the Pfizer-BioNTech vaccine for use against COVID-19 and said that it will be rolled out from next week. …
-
The vaccine is expected to be rolled out from next week. Britain on Wednesday became the first country in the world to approve the Pfizer-BioNTech vaccine for use and said …
-
A worker passes a line of freezers holding coronavirus disease (COVID-19) vaccine candidate BNT162b2 at a Pfizer facility in Puurs, Belgium in an undated photograph. Pfizer | via Reuters The …
- General
US to distribute 6.4 million doses of Pfizer-BioNTech COVID-19 vaccine in first tranche by year-end – World News , Firstpost
The federal government will issue recommendations for who should be prioritised — likely the elderly, high-risk, and frontline workers — but local authorities will make the final call Pfizer vaccines …
- 1
- 2